A previous study examining serum-soluble PD-L1 (sPD-L1) levels in colorectal cancer patients who underwent chemoradiation therapy (CRT) showed that sPD-L1 levels increased significantly after CRT (p < 0.0001) [9]. Here, SPDL1 is linked to colorectal cancer.